1. Home
  2. AVIR vs RLTY Comparison

AVIR vs RLTY Comparison

Compare AVIR & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVIR
  • RLTY
  • Stock Information
  • Founded
  • AVIR 2012
  • RLTY 2022
  • Country
  • AVIR United States
  • RLTY United States
  • Employees
  • AVIR N/A
  • RLTY N/A
  • Industry
  • AVIR Medicinal Chemicals and Botanical Products
  • RLTY Investment Managers
  • Sector
  • AVIR Health Care
  • RLTY Finance
  • Exchange
  • AVIR Nasdaq
  • RLTY Nasdaq
  • Market Cap
  • AVIR 276.9M
  • RLTY 277.8M
  • IPO Year
  • AVIR 2020
  • RLTY N/A
  • Fundamental
  • Price
  • AVIR $3.50
  • RLTY $16.59
  • Analyst Decision
  • AVIR Hold
  • RLTY
  • Analyst Count
  • AVIR 1
  • RLTY 0
  • Target Price
  • AVIR $6.88
  • RLTY N/A
  • AVG Volume (30 Days)
  • AVIR 152.9K
  • RLTY 86.7K
  • Earning Date
  • AVIR 11-07-2024
  • RLTY 01-01-0001
  • Dividend Yield
  • AVIR N/A
  • RLTY 9.35%
  • EPS Growth
  • AVIR N/A
  • RLTY N/A
  • EPS
  • AVIR N/A
  • RLTY N/A
  • Revenue
  • AVIR N/A
  • RLTY N/A
  • Revenue This Year
  • AVIR N/A
  • RLTY N/A
  • Revenue Next Year
  • AVIR N/A
  • RLTY N/A
  • P/E Ratio
  • AVIR N/A
  • RLTY N/A
  • Revenue Growth
  • AVIR N/A
  • RLTY N/A
  • 52 Week Low
  • AVIR $2.77
  • RLTY $11.38
  • 52 Week High
  • AVIR $4.60
  • RLTY $14.60
  • Technical
  • Relative Strength Index (RSI)
  • AVIR 51.68
  • RLTY 51.98
  • Support Level
  • AVIR $3.42
  • RLTY $15.81
  • Resistance Level
  • AVIR $3.62
  • RLTY $16.52
  • Average True Range (ATR)
  • AVIR 0.13
  • RLTY 0.29
  • MACD
  • AVIR 0.01
  • RLTY -0.02
  • Stochastic Oscillator
  • AVIR 70.00
  • RLTY 73.61

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest

Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.

Share on Social Networks: